Folgen
Jason R. Thomas
Jason R. Thomas
Novartis Biomedical Research
Bestätigte E-Mail-Adresse bei novartis.com
Titel
Zitiert von
Zitiert von
Jahr
Targeting RNA with small molecules
JR Thomas, PJ Hergenrother
Chemical reviews 108 (4), 1171-1224, 2008
6702008
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo
WE Dowdle, B Nyfeler, J Nagel, RA Elling, S Liu, E Triantafellow, ...
Nature cell biology 16 (11), 1069-1079, 2014
6462014
SMN2 splice modulators enhance U1–pre-mRNA association and rescue SMA mice
J Palacino, SE Swalley, C Song, AK Cheung, L Shu, X Zhang, ...
Nature chemical biology 11 (7), 511-517, 2015
4132015
Harnessing the anti-cancer natural product nimbolide for targeted protein degradation
JN Spradlin, X Hu, CC Ward, SM Brittain, MD Jones, L Ou, M To, ...
Nature chemical biology 15 (7), 747-755, 2019
3052019
Drug discovery considerations in the development of covalent inhibitors
R Mah, JR Thomas, CM Shafer
Bioorganic & medicinal chemistry letters 24 (1), 33-39, 2014
2432014
Covalent ligand screening uncovers a RNF4 E3 ligase recruiter for targeted protein degradation applications
CC Ward, JI Kleinman, SM Brittain, PS Lee, CYS Chung, K Kim, Y Petri, ...
ACS chemical biology 14 (11), 2430-2440, 2019
2292019
Size-specific ligands for RNA hairpin loops
JR Thomas, X Liu, PJ Hergenrother
Journal of the American Chemical Society 127 (36), 12434-12435, 2005
2122005
Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes
E Dominguez, A Galmozzi, JW Chang, KL Hsu, J Pawlak, W Li, C Godio, ...
Nature chemical biology 10 (2), 113-121, 2014
1332014
Nannocystin A: an elongation factor 1 inhibitor from myxobacteria with differential anti‐cancer properties
P Krastel, S Roggo, M Schirle, NT Ross, F Perruccio, P Aspesi Jr, T Aust, ...
Angewandte Chemie International Edition 54 (35), 10149-10154, 2015
1032015
Combating drug-resistant bacteria: small molecule mimics of plasmid incompatibility as antiplasmid compounds
JCB DeNap, JR Thomas, DJ Musk, PJ Hergenrother
Journal of the American Chemical Society 126 (47), 15402-15404, 2004
682004
Deoxystreptamine dimers bind to RNA hairpin loops
X Liu, JR Thomas, PJ Hergenrother
Journal of the American Chemical Society 126 (30), 9196-9197, 2004
662004
Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1
JW Thompson, J Nagel, S Hoving, B Gerrits, A Bauer, JR Thomas, ...
Journal of Biological Chemistry 289 (42), 28942-28955, 2014
632014
CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing’s sarcoma
NT Ross, F Lohmann, S Carbonneau, A Fazal, WA Weihofen, S Gleim, ...
Nature chemical biology 16 (1), 50-59, 2020
622020
Discovery of a ZIP7 inhibitor from a Notch pathway screen
E Nolin, S Gans, L Llamas, S Bandyopadhyay, SM Brittain, ...
Nature chemical biology 15 (2), 179-188, 2019
572019
Biochemical and thermodynamic characterization of compounds that bind to RNA hairpin loops: toward an understanding of selectivity
JR Thomas, X Liu, PJ Hergenrother
Biochemistry 45 (36), 10928-10938, 2006
532006
Gift from nature: Cyclomarin A kills mycobacteria and malaria parasites by distinct modes of action
N Bürstner, S Roggo, N Ostermann, J Blank, C Delmas, F Freuler, ...
ChemBioChem 16 (17), 2433-2436, 2015
472015
The glycerophospho metabolome and its influence on amino acid homeostasis revealed by brain metabolomics of GDE1 (−/−) mice
F Kopp, T Komatsu, DK Nomura, SA Trauger, JR Thomas, G Siuzdak, ...
Chemistry & biology 17 (8), 831-840, 2010
432010
Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells
D Estoppey, JW Hewett, CT Guy, E Harrington, JR Thomas, M Schirle, ...
Scientific reports 7 (1), 42728, 2017
372017
The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid
JR Thomas, JCB DeNap, ML Wong, PJ Hergenrother
Biochemistry 44 (18), 6800-6808, 2005
372005
Conversion of a single polypharmacological agent into selective bivalent inhibitors of intracellular kinase activity
CM Gower, JR Thomas, E Harrington, J Murphy, MEK Chang, ...
ACS chemical biology 11 (1), 121-131, 2016
282016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20